Eleonora Riccio

10PUBLICATIONS
27CO-AUTHORS
Nutrigenomics and personalised nutritionNaturopathyCancer therapy (excl. chemotherapy and radiation therapy)Cell development, proliferation and deathRegenerative medicine (incl. stem cells)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|May 20, 2026
DUAL GIP/GLP-1Ra reduces residual proteinuria in non-diabetic fabry disease.

|Aug 12, 2025
Real-World Migalastat Use in Fabry Disease: Comparative Insights From the Pisani and Hughes Studies.

Eleonora Riccio, Antonio Pisani

|Nov 14, 2022
New insights in efficacy of different enzyme replacement therapy dosages in Fabry disease: Switch studies data following agalsidase beta shortage.

Eleonora Riccio, Antonio Pisani

|Mar 23, 2021
Stepwise shortening of agalsidase beta infusion duration in Fabry disease: Clinical experience with infusion rate escalation protocol.

Eleonora Riccio, Mario Zanfardino, Monica Franzese

|Jul 11, 2020
Switch from enzyme replacement therapy to oral chaperone migalastat for treating fabry disease: real-life data.

Eleonora Riccio, Mario Zanfardino, Lucia Ferreri

|Feb 24, 2020
Oral Sucrosomial® iron versus intravenous iron for recovering iron deficiency anaemia in ND-CKD patients: a cost- minimization analysis.

Eleonora Riccio, Massimo Sabbatini, Ivana Capuano

Pageof 2

Frequent Collaborators

2 joint publications

Massimo Sabbatini

2 joint publications

Gaia Peluso

2 joint publications

Paola Incollingo

2 joint publications

Nicola Carlomagno